The risk of neoplasms in appendiceal abscess: what emergency surgeons should know - Top-Institutions - MDSpire

The risk of neoplasms in appendiceal abscess: what emergency surgeons should know

  • By

  • Giulia Montori

  • Mauro Podda

  • Alessio Giordano

  • Giuseppa Procida

  • Vittoria Butera

  • Valentina Murzi

  • Paola Fugazzola

  • Carlo Bergamini

  • Fausto Catena

  • Luca Ansaloni

  • Adolfo Pisanu

  • Ferdinando Agresta

  • May 4, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Emergency Medicine

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology
    • Emergency Medicine

  • #3

    University of Maryland School of Medicine
    University of Maryland School of Medicine

    Baltimore, Maryland

    Key Differentiators

    • Surgery
    • Emergency Medicine

  • #4

    Yale School of Medicine
    Yale School of Medicine

    New Haven, Connecticut

    Key Differentiators

    • Surgery
    • Emergency Medicine

  • #5

    Erasmus University Medical Centre
    Erasmus University Medical Centre

    Rotterdam, Netherlands

    Key Differentiators

    • Surgery
    • Emergency Medicine

Original Source(s)

The risk of neoplasms in appendiceal abscess: what emergency surgeons should know

  • by Giulia Montori, Mauro Podda, Alessio Giordano, Giuseppa Procida, Vittoria Butera, Valentina Murzi, Paola Fugazzola, Carlo Bergamini, Fausto Catena, Luca Ansaloni, Adolfo Pisanu, Ferdinando Agresta

  • May 4, 2026

Related Content

Understanding cardiac toxicity and immune responses to thoracic radiation therapy in non-small cell lung cancer – implications for future research

Beyond inhibition: harnessing the DRD2–VEGF-A feedback loop for precision anti-angiogenesis therapy in cancer

Treatment evolution and survival impact of consolidation therapies in mantle cell lymphoma: insights from an Asia-Pacific real-world registry